Lara A Kahale
Overview
Explore the profile of Lara A Kahale including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1017
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Akl E, Khabsa J, Iannizzi C, Piechotta V, Kahale L, Barker J, et al.
BMJ
. 2024 Nov;
387:e079183.
PMID: 39562017
No abstract available.
2.
Kahale L, Piechotta V, McKenzie J, Dorando E, Iannizzi C, Barker J, et al.
F1000Res
. 2024 May;
11:109.
PMID: 38813137
: While the PRISMA 2020 statement is intended to guide the reporting of original systematic reviews, updated systematic reviews, and living systematic reviews (LSRs), its explanation and elaboration document notes...
3.
Iannizzi C, Akl E, Anslinger E, Weibel S, Kahale L, Aminat A, et al.
Syst Rev
. 2023 Dec;
12(1):238.
PMID: 38098023
Background And Objective: The living systematic review (LSR) approach is based on ongoing surveillance of the literature and continual updating. Most currently available guidance documents address the conduct, reporting, publishing,...
4.
Akl E, El Khoury R, Khamis A, El Mikati I, Pardo-Hernandez H, Farran S, et al.
J Clin Epidemiol
. 2023 Feb;
156:11-21.
PMID: 36764466
Objectives: The objectives of this study are to describe the characteristics of living systematic reviews (LSRs) and to understand their life cycles. Study Design And Setting: We conducted a comprehensive...
5.
Khabsa J, Chang S, McKenzie J, Barker J, Boutron I, Kahale L, et al.
J Clin Epidemiol
. 2023 Feb;
156:113-118.
PMID: 36736707
Objectives: As part of an effort to develop an extension of the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) 2020 statement for living systematic reviews (LSRs), we discuss...
6.
Iannizzi C, Akl E, Kahale L, Dorando E, Aminat A, Barker J, et al.
F1000Res
. 2022 Feb;
10:802.
PMID: 35186269
The living systematic review (LSR) approach is based on an ongoing surveillance of the literature and continual updating. A few guidance documents address the conduct, reporting, publishing and appraisal of...
7.
Kahale L, Elkhoury R, El Mikati I, Pardo-Hernandez H, Khamis A, Schunemann H, et al.
F1000Res
. 2022 Feb;
10:192.
PMID: 35136567
: While the PRISMA flow diagram is widely used for reporting standard systematic reviews (SRs), it was not designed for capturing the results of continual searches for studies in living...
8.
Kahale L, Matar C, Hakoum M, Tsolakian I, Yosuico V, Terrenato I, et al.
Cochrane Database Syst Rev
. 2021 Dec;
12:CD006649.
PMID: 34878173
Background: Compared with people without cancer, people with cancer who receive anticoagulant treatment for venous thromboembolism (VTE) are more likely to develop recurrent VTE. Objectives: To compare the efficacy and...
9.
Kahale L, Matar C, Tsolakian I, Hakoum M, Barba M, Yosuico V, et al.
Cochrane Database Syst Rev
. 2021 Oct;
10:CD006466.
PMID: 34622445
Background: Oral anticoagulants may improve the survival of people with cancer through an antithrombotic effect, yet increase the risk of bleeding. Objectives: To evaluate the efficacy and safety of oral...
10.
Kahale L, Matar C, Tsolakian I, Hakoum M, Yosuico V, Terrenato I, et al.
Cochrane Database Syst Rev
. 2021 Sep;
9:CD014739.
PMID: 34582035
Background: Multiple myeloma is a malignant plasma cell disorder characterised by clonal plasma cells that cause end-organ damage such as renal failure, lytic bone lesions, hypercalcaemia and/or anaemia. People with...